Osborne Partners Capital Management LLC boosted its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 2.1% during the second quarter, Holdings Channel reports. The fund owned 61,966 shares of the medical research company’s stock after buying an additional 1,299 shares during the period. Thermo Fisher Scientific accounts for approximately 1.5% of Osborne Partners Capital Management LLC’s portfolio, making the stock its 15th largest position. Osborne Partners Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $10,811,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Thermo Fisher Scientific by 2.7% in the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock worth $3,989,193,000 after buying an additional 695,079 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock worth $3,531,095,000 after buying an additional 22,165,530 shares during the last quarter. State Street Corp boosted its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock worth $2,470,802,000 after buying an additional 164,367 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Thermo Fisher Scientific by 5.6% in the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock worth $1,153,867,000 after buying an additional 398,622 shares during the last quarter. Finally, Morgan Stanley boosted its stake in shares of Thermo Fisher Scientific by 7.6% in the first quarter. Morgan Stanley now owns 4,664,882 shares of the medical research company’s stock worth $716,526,000 after buying an additional 327,826 shares during the last quarter. Institutional investors and hedge funds own 87.60% of the company’s stock.

Thermo Fisher Scientific Inc (NYSE TMO) traded up 0.32% on Monday, reaching $173.78. The company had a trading volume of 526,737 shares. The stock’s 50 day moving average price is $176.78 and its 200-day moving average price is $165.46. The stock has a market capitalization of $67.79 billion, a PE ratio of 30.28 and a beta of 1.06. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $182.87.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. Thermo Fisher Scientific’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.03 EPS. Equities analysts expect that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.35%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

WARNING: “Thermo Fisher Scientific Inc (TMO) Shares Bought by Osborne Partners Capital Management LLC” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/thermo-fisher-scientific-inc-tmo-shares-bought-by-osborne-partners-capital-management-llc/1486968.html.

A number of equities research analysts have issued reports on TMO shares. Cantor Fitzgerald started coverage on shares of Thermo Fisher Scientific in a report on Thursday, May 18th. They set an “overweight” rating and a $194.00 target price on the stock. Barclays PLC set a $175.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Wednesday, April 26th. Cowen and Company reissued an “outperform” rating and set a $185.00 target price (up previously from $175.00) on shares of Thermo Fisher Scientific in a report on Saturday, April 29th. Citigroup Inc. reissued a “buy” rating and set a $201.00 target price (up previously from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Finally, BidaskClub raised shares of Thermo Fisher Scientific from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 11th. One analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $188.56.

In other Thermo Fisher Scientific news, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction on Monday, June 5th. The shares were sold at an average price of $176.26, for a total value of $440,650.00. Following the sale, the chief financial officer now directly owns 37,790 shares in the company, valued at approximately $6,660,865.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Daniel P. Shine sold 4,688 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $171.88, for a total transaction of $805,773.44. Following the completion of the sale, the insider now owns 29,200 shares in the company, valued at $5,018,896. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,188 shares of company stock worth $4,702,223. 0.49% of the stock is currently owned by insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.